Home / Founders / Josh Mandel-Brehm

Josh Mandel-Brehm

Founder of CAMP4 Therapeutics

Backed by

EcoR1 Capital
Oleg Nodelman

Sources

CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock — 2025-12

Browse all founders · Browse investors